Business Services Industry
Theregen Announces Equity Investment from Guidant Corporation to Develop Anginera™ Epicardial Patch
Business Wire, Feb 7, 2006
SAN FRANCISCO -- Theregen Corporation today announced that it has received an equity investment from Guidant Corporation (NYSE:GDT), a worldwide leader in the treatment of cardiovascular disease.
Theregen is developing Anginera(TM) as a treatment for diffuse small vessel coronary artery disease. In 2005, Theregen received FDA approval to proceed with a Phase I safety trial for patients suffering from this cardiovascular disorder. The product will serve as an adjunct therapy to revascularization procedures that include coronary artery bypass graft surgery. The company intends to initiate its Anginera Phase I safety trial in this quarter.
"We believe our Anginera(TM) therapy has the potential to benefit patients suffering from a variety of chronic, debilitating cardiovascular diseases," said Theregen CEO Thomas A. Schreck. "We are very pleased to announce this strategic investment for Theregen, not only due to the capital it affords to advance our clinical program, but also for the access to highly regarded professionals within Guidant."
"We believe that Theregen's approach to delivering cell-based therapies epicardially is promising. Guidant is pleased to be able to support innovative technologies such as Anginera(TM) that hold the opportunity to significantly improve the quality of life for patients undergoing cardiac surgery procedures," said Maria Degois-Sainz, President, Cardiac Surgery, Guidant.
Theregen Corporation is a regenerative medicine company that develops cell-based therapies for patients with cardiovascular and vascular disease. Theregen's primary corporate objective is the clinical development and approval of Anginera(TM), its lead product candidate. Theregen is located in San Francisco, Calif., with research and development facilities in Tucson, Ariz.
Guidant Corporation, Indianapolis, Ind., pioneers lifesaving technology, giving an opportunity for better life today to millions of cardiac and vascular patients worldwide. The company develops, manufactures and markets a broad array of products and services that enable less invasive care for some of life's most threatening medical conditions.
- 5 Rules for Immediate Annuities
- Death in the Family: 12 Things to Do Now
- Dumbest Things You Do With Your Money
- 6 Online Networking Mistakes to Avoid
- 401(k) Mistakes to Avoid
- 5 Economic Scenarios to Keep You Up at Night
- The Real ‘Best Places to Retire’
- Best Credit Cards for You
- 12 Tough Questions to Ask Your Parents
- The Real ‘Best Colleges’
- Home Buyer Tax Credit: How to Cash In
- Why You Shouldn't Bash Cash
- 8 Phony 'Bargains' and Better Alternatives
- Danger: 3 Debit Card Scams to Avoid
- 6 Myths About Gas Mileage
- 29 Fees We Hate Most
- Quick and Easy Ways to Boost Returns
- Best Stocks to Buy Now
- Lower Your Taxes: 10 Moves to Make Now
- New Jobs: 8 Lessons from Real-Life Career Switchers
- The New Job Market: Who Wins and Who Loses?
- Health Care Reform's Public Option: Everything You Need to Know
- Volunteer Work When Unemployed: Should You Work for Free?
- Whose Recovery Is This?
- Long-Term-Care Insurance: 4 Biggest Risks to Avoid
Content provided in partnership with
Most Recent Business Articles
- "Do not rely on a single economy" ; Larsen and Toubro (L and T) was affected due to the slowdown particularly the products businesses, which include switchgears, construction equipment and industrial bars.
- "The first deliberate call we took was not to lay off anybody" ; The diversified group decided to reskill all surplus workers.
- "Government had to step up its demand" ; The downturn affected the government as much as India Inc. The outgoing advisor to the Government of India details its impact and its lessons.
- "Help your customers even in difficult times" ; Oil was at an all-time high at over $135 per barrel just before the financial meltdown. Then oil crashed to a low of $35 per barrel in January this year, bringing down any fresh demand for pipes fr
- "You have to be visible as a leader" ; Transparency is a standard operating procedure for communications during a downturn.
Most Recent Business Publications
Most Popular Business Articles
- 7 tips for effective listening: productive listening does not occur naturally. It requires hard work and practice - Back To Basics - effective listening is a crucial skill for internal auditors
- Using object-oriented analysis and design over traditional structured analysis and design
- FAS 109: a primer for non-accountants - Financial Accounting Standards Board's "Statement 109: Accounting for Income Taxes"
- LIFO vs. FIFO: a return to the basics
- Design a commission plan that drives sales - Sales Commissions
